XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended 21 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Mar. 31, 2025
Mar. 31, 2024
Sep. 30, 2025
Cash flows from operating activities:              
Net income (loss) $ (17,907) $ 9,747 $ (110,555) $ 54,057      
Adjustments to reconcile net income (loss) to net cash used in operating activities:              
Depreciation and amortization     385 805      
Net amortization of debt premium and discount (related party of $182 and $99)     182 99      
Loss on impairment of goodwill 0 298 0 3,692     $ 2,400,000
Loss on financial instruments, net (related party of $(5) and $(538)) (211) 179 (166) 1,362      
Investment income (loss), net 3,162 (8,541) 15,938 (19,569)      
Non cash interest expense (related party of $5,573 and $4,622)     7,364 6,584      
Non cash interest income     (256) 0      
Non cash share-based compensation     923 4,358      
Provision for credit losses 0 476 0 1,000      
Accrual (release) of loss contingency related to arbitration award 0 0 62,831 (54,973)   $ 55,000  
Provision for deferred taxes     43 0      
(Gain) loss on liability resolution 0 (23,462) 0 (23,462)      
Changes in assets and liabilities:              
Changes in other assets     (955) 168      
Changes in accounts payable and accrued expenses     (1,098) 6,710      
Changes in other liabilities and deferred revenue     0 (90)      
Net cash used in operating activities     (25,364) (19,259)      
Cash flows from investing activities:              
Return of investments in alternative assets held by Customer ExAlt Trusts     7,780 12,547 $ 47,800    
Proceeds from disposition of alternative assets held by Customer ExAlt Trusts     37,174 0      
Purchase of investments in alternative assets held by Customer ExAlt Trusts     (2,033) (450)      
Purchase of premises and equipment     (96) (933)      
Net cash provided by investing activities     42,825 11,164      
Cash flows from financing activities:              
Proceeds from related party debt financings     850 1,675      
Payments on related party debt financings     (15,026) (200)      
Proceeds from issuance of convertible debt     0 1,775      
Proceeds received from issuance of Class A common shares under equity purchase agreement     271 2,555      
Payment of deferred financing costs for equity     0 (1,564)      
Proceeds from sale of Class A common shares     0 673      
Net cash (used in) provided by financing activities     (13,905) 4,914      
Net increase (decrease) in cash and cash equivalents     3,556 (3,181)      
Cash and cash equivalents at beginning of period     1,346 7,977 7,977    
Cash and cash equivalents at end of period $ 4,902 $ 4,796 $ 4,902 $ 4,796 $ 1,346 $ 7,977 $ 4,902